Cargando…
Blood-Based Biomarkers for the Optimization of Anti-Angiogenic Therapies
The dependence of tumor growth and metastasis on blood vessels makes tumor angiogenesis a rational target for therapy. Strategies have been pursued to inhibit neovascularization and to destroy existing tumor vessels, or both. These include direct targeting of endothelial cells, and indirect targetin...
Autores principales: | Rabascio, Cristina, Bertolini, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835117/ https://www.ncbi.nlm.nih.gov/pubmed/24281105 http://dx.doi.org/10.3390/cancers2021027 |
Ejemplares similares
-
Biomarkers for Anti-Angiogenic Therapy in Cancer
por: Wehland, Markus, et al.
Publicado: (2013) -
Biomarkers in Tumor Angiogenesis and Anti-Angiogenic Therapy
por: Pircher, Andreas, et al.
Publicado: (2011) -
Molecular biomarker‐guided anti‐angiogenic targeted therapy for malignant glioma
por: Yan, Chengrui, et al.
Publicado: (2019) -
Nephrotoxicity of Anti-Angiogenic Therapies
por: Van Wynsberghe, Margaux, et al.
Publicado: (2021) -
Angiogenic signaling pathways and anti-angiogenic therapy for cancer
por: Liu, Zhen-Ling, et al.
Publicado: (2023)